ArticlePloS one2026
Cultural adaptation and content validation of the WHO BeSD framework for HPV vaccination in Pakistan: A two-phase Delphi and cognitive interview study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe BeSD Framework (Behavioral and Social Drivers of Vaccination), developed by the World Health Organization, provides a structured approach to understanding the behavior and social drivers of vaccine uptake. However, it's direct use in diverse cultural backgrounds especially in the context of HPV vaccination, is not yet established. Therefore, this study aimed to culturally adapt and establish content validity of the BeSD framework for assessing behavioral and social drivers of Human papillomavirus (HPV) vaccination in Pakistan.
methodsA two-phase multi-method cross-cultural adaptation with expert content validation and cognitive interviews was used following the emic-etic paradigm and globally accepted Beaton's cross-cultural adaptation guidelines. The initial items of the BeSD-HPV tool were translated into Urdu through forward-backward translation and expert synthesis. Content validity was assessed using a two-round Delphi method with ten multidisciplinary experts, who rated items on a four-point relevance and clarity scale. Consensus was a priori defined as item-level content validity index scores of ≥0.80. A scale-level content validity index score was also calculated. Response-process validity was then evaluated through cognitive interviews with 30 caregivers of adolescent girls using think-aloud and probing techniques to assess comprehension and cultural appropriateness.
resultsTen experts participated in both rounds of the online Delphi study. At the completion of the study, out of the initial 75 items, two items were dropped in round one and three items were dropped in round 2. Out of the total 73 left in round 1, 28 items were accepted by all experts without revision, 42 were revised in rounds 2 and 3 were dropped in round 2, resulting in a 70-item BeSD-HPV tool. The scale-level content validity index score for the final 70-item instrument was 0.96. Cognitive interviews using the think-aloud technique and probing were conducted with parents/caregivers of girls aged 9-16 years. A total of 30 interviews were conducted. Seventeen items categorized as having minor or major issues were revised by the authors based on participant feedback to improve comprehension.
conclusionThe adapted BeSD-HPV tool demonstrated strong content and response-process validity for the Pakistani context. This culturally sensitive instrument will support future large-scale studies to determine the construct validity and reliability of the BeSD-HPV, thereby providing a validated tool to assess drivers of HPV vaccine acceptance and inform future context-specific demand generation strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.